SCHEMBL1337532

SCHEMBL1337532

COc1cc(C(=O)c2cccc3ncccc23)cc(OC)c1OC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.65
HSD17B10 Q99714 1/20 0.65
L3MBTL1 Q9Y468 1/20 0.65
TUBB4A P04350 8/20 0.57
TUBB P07437 8/20 0.57
TUBA3C P0DPH7 8/20 0.57
TUBA1B P68363 8/20 0.57
TUBA4A P68366 8/20 0.57
TUBB4B P68371 8/20 0.57
TUBB3 Q13509 8/20 0.57
TUBB2A Q13885 8/20 0.57
TUBB8 Q3ZCM7 8/20 0.57
TUBA3E Q6PEY2 8/20 0.57
TUBA1A Q71U36 8/20 0.57
TUBA1C Q9BQE3 8/20 0.57
TUBB6 Q9BUF5 8/20 0.57
TUBB2B Q9BVA1 8/20 0.57
TUBB1 Q9H4B7 8/20 0.57
SYK P43405 1/20 0.52
KDM4E B2RXH2 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1336449 0.91 SMN1; SMN2 (0.57) SMN1; SMN2HSD17B10L3MBTL1TUBB4ATUBB
SCHEMBL12130384 0.83 SMN1; SMN2 (0.47) SMN1; SMN2HSD17B10L3MBTL1TUBB4ATUBB
SCHEMBL1336724 0.81 MEN1 (0.65) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL6103129 0.80 TUBB4A (0.64) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL1337756 0.80 TUBB4A (0.54) SMN1; SMN2HSD17B10L3MBTL1TUBB4ATUBB
SCHEMBL27719184 0.77 NSD2 (0.58) SMN1; SMN2L3MBTL1KDM4EMAPTMEN1
SCHEMBL7374498 0.76 GCGR (0.59) SMN1; SMN2HSD17B10L3MBTL1KDM4EMAPT
SCHEMBL1337935 0.75 TUBB4A (0.55) SMN1; SMN2HSD17B10L3MBTL1TUBB4ATUBB
SCHEMBL1336755 0.75 ALOX15 (0.60) SMN1; SMN2HSD17B10L3MBTL1TUBB4ATUBB
SCHEMBL12130376 0.75 ALDH1A1 (0.45) SMN1; SMN2HSD17B10L3MBTL1TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110275643-A1 AROYLQUINOLINE COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2011-11-10 US disclosed
US-20110275643-A1 AROYLQUINOLINE COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2011-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275643-A1 AROYLQUINOLINE COMPOUNDS TUBA1C, TUBB1, TUBB3 SMN1; SMN2 1630/4885HSD17B10 3886/4885L3MBTL1 2707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.